KAT2B and breast carcinoma: Interestingly, knockdown of GCN5 was shown to inhibit EMT and decrease the migration and invasion of MDA-MB-231 breast cancer cells, which was associated with decreased expression of p-STAT3, p-AKT, MMP9, and E2F1, and increased expression of P21.